268 related articles for article (PubMed ID: 31323332)
1. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer.
Zeng JD; Wu WKK; Wang HY; Li XX
Pharmacol Res; 2019 Nov; 149():104352. PubMed ID: 31323332
[TBL] [Abstract][Full Text] [Related]
2. Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism.
Zhao T; Fan J; Abu-Zaid A; Burley SK; Zheng XFS
Cells; 2024 May; 13(9):. PubMed ID: 38727317
[TBL] [Abstract][Full Text] [Related]
3. mTOR Signaling in Metabolism and Cancer.
Huang S
Cells; 2020 Oct; 9(10):. PubMed ID: 33065976
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells.
Chiarini F; Evangelisti C; Lattanzi G; McCubrey JA; Martelli AM
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1322-1337. PubMed ID: 30928610
[TBL] [Abstract][Full Text] [Related]
5. mTOR Signaling in Growth, Metabolism, and Disease.
Saxton RA; Sabatini DM
Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
[TBL] [Abstract][Full Text] [Related]
6. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
Zubova SG; Shitikova ZhV; Pospelova TV
Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
[TBL] [Abstract][Full Text] [Related]
7. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
8. LKB1 loss links serine metabolism to DNA methylation and tumorigenesis.
Kottakis F; Nicolay BN; Roumane A; Karnik R; Gu H; Nagle JM; Boukhali M; Hayward MC; Li YY; Chen T; Liesa M; Hammerman PS; Wong KK; Hayes DN; Shirihai OS; Dyson NJ; Haas W; Meissner A; Bardeesy N
Nature; 2016 Nov; 539(7629):390-395. PubMed ID: 27799657
[TBL] [Abstract][Full Text] [Related]
9. mTOR: Role in cancer, metastasis and drug resistance.
Murugan AK
Semin Cancer Biol; 2019 Dec; 59():92-111. PubMed ID: 31408724
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic mTOR: the rookie energy sensor.
Martínez de Morentin PB; Martinez-Sanchez N; Roa J; Ferno J; Nogueiras R; Tena-Sempere M; Dieguez C; Lopez M
Curr Mol Med; 2014 Jan; 14(1):3-21. PubMed ID: 24236459
[TBL] [Abstract][Full Text] [Related]
11. Role of mTOR Signaling in Tumor Microenvironment: An Overview.
Conciatori F; Bazzichetto C; Falcone I; Pilotto S; Bria E; Cognetti F; Milella M; Ciuffreda L
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126252
[TBL] [Abstract][Full Text] [Related]
12. Polyphyllin VI, a saponin from Trillium tschonoskii Maxim. induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer.
Teng JF; Qin DL; Mei QB; Qiu WQ; Pan R; Xiong R; Zhao Y; Law BY; Wong VK; Tang Y; Yu CL; Zhang F; Wu JM; Wu AG
Pharmacol Res; 2019 Sep; 147():104396. PubMed ID: 31404628
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Target of Rapamycin Is a Novel Molecular Mechanism Linking Folate Availability and Cell Function.
Silva E; Rosario FJ; Powell TL; Jansson T
J Nutr; 2017 Jul; 147(7):1237-1242. PubMed ID: 28592519
[TBL] [Abstract][Full Text] [Related]
15. Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.
Reina-Campos M; Linares JF; Duran A; Cordes T; L'Hermitte A; Badur MG; Bhangoo MS; Thorson PK; Richards A; Rooslid T; Garcia-Olmo DC; Nam-Cha SY; Salinas-Sanchez AS; Eng K; Beltran H; Scott DA; Metallo CM; Moscat J; Diaz-Meco MT
Cancer Cell; 2019 Mar; 35(3):385-400.e9. PubMed ID: 30827887
[TBL] [Abstract][Full Text] [Related]
16. mTOR signaling in disease.
Dazert E; Hall MN
Curr Opin Cell Biol; 2011 Dec; 23(6):744-55. PubMed ID: 21963299
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Post-Translational Modifications on mTOR Signaling.
Yin S; Liu L; Gan W
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670113
[TBL] [Abstract][Full Text] [Related]
18. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.
Tian T; Li X; Zhang J
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754640
[TBL] [Abstract][Full Text] [Related]
19. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
Audet-Walsh É; Dufour CR; Yee T; Zouanat FZ; Yan M; Kalloghlian G; Vernier M; Caron M; Bourque G; Scarlata E; Hamel L; Brimo F; Aprikian AG; Lapointe J; Chevalier S; Giguère V
Genes Dev; 2017 Jun; 31(12):1228-1242. PubMed ID: 28724614
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial AKAP1 supports mTOR pathway and tumor growth.
Rinaldi L; Sepe M; Delle Donne R; Conte K; Arcella A; Borzacchiello D; Amente S; De Vita F; Porpora M; Garbi C; Oliva MA; Procaccini C; Faicchia D; Matarese G; Zito Marino F; Rocco G; Pignatiello S; Franco R; Insabato L; Majello B; Feliciello A
Cell Death Dis; 2017 Jun; 8(6):e2842. PubMed ID: 28569781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
